Could CBD help spinal cord injury patients regain bladder control?

NCT ID NCT06840899

Recruiting now Symptom relief Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether cannabidiol (CBD), a compound from cannabis, can reduce urinary incontinence in people with recent spinal cord injury. Twenty adults with at least two leaks per day will take a purified CBD drug (Epidiolex) twice daily for 90 days. The main goal is to see if participants stick with the treatment and to track any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cannabidiol (CBD, Epidiolex)
What this could lead to: If it works, this could point toward a new way to manage bladder control problems after spinal cord injury.
What could go wrong: This is a small, early feasibility study with only 20 participants. It is designed mainly to see if people will take the drug as directed, not to prove it works. CBD may cause side effects like drowsiness or liver issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL CORD INJURY SUPRA-SACRAL SPINAL CORD INJURY URINARY INCONTINENCE

Contacts and locations

Locations

University of Wisconsin - Madison
RECRUITING

Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.